http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112016002770-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7656222349a1d2b5669911a8f83c37cf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2014-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c79303ac8e93d8f0a33d15a4ab13f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10197ee0c63a1e812a9a99e97ad863ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca9ebb547d2d4498699c91362c9ee457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502311e2248998a4d525357dd58fd038
publicationDate 2022-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112016002770-B1
titleOfInvention 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID HEMISULFATE SALT, ITS PHARMACEUTICAL COMPOSITION AND ITS USE
abstract 5,10-METHYLENE-(6R)-TETRAHYDROPHOLIC ACID HEMISULFATE SALT, ITS PHARMACEUTICAL COMPOSITION AND ITS USE. The present invention is directed to 5,10-methylene-(6R)-tetrahydrofolic acid hemisulfate salt, preferably in substantially crystalline form, as well as pharmaceutical compositions and uses thereof in therapy, preferably chemotherapy.
priorityDate 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581977

Total number of triples: 33.